D. Baldwin

Publications514
h-index60
Citations11,761
Highly Influential Citations493
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • D. Nutt
  • 706 Publications • 26,340 Citations
  • S. Kasper
  • 466 Publications • 11,785 Citations
  • H. Wittchen
  • 482 Publications • 19,905 Citations
  • H. Möller
  • 263 Publications • 14,198 Citations
  • Publications
  • Influence
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for…
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and… Expand
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)
TLDR
None of the active treatment groups, including duloxetine, separated from placebo in the primary analysis in this 'failed' study, and findings on secondary outcome measures were supportive of likely efficacy. Expand
Antidepressants and their effect on sleep
TLDR
The effect on sleep varies between compounds within antidepressant classes, differences relating to the amount of sedative or alerting (insomnia) effects, changes to baseline sleep parameters, Differences relating to REM sleep, and the degree of sleep‐related side effects. Expand
Depression and sexual dysfunction.
  • D. Baldwin
  • Medicine
  • British medical bulletin
  • 1 March 2001
TLDR
There is a need for further studies of the effects of antidepressants on sexual function, as accurate identification of the incidence of treatment-emergent dysfunction has proved troublesome. Expand
Transcranial direct current stimulation (tDCS) in the treatment of depression: Systematic review and meta-analysis of efficacy and tolerability
TLDR
The data do not support the use of tDCS in treatment-resistant depression, or as an add-on augmentation treatment, and tDCS may be efficacious for treatment of MDE. Expand
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
  • D. Baldwin, I. Anderson, +8 authors H. -U. Wittchen
  • Psychology, Medicine
  • Journal of psychopharmacology
  • 1 November 2005
TLDR
These British Association for Psychopharmacology guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments. Expand
Social functioning in depression: a review.
TLDR
This article reviews the available data on social functioning in depression and provides clinical guidelines and opinion on this important and expanding field and it is becoming clear that not all treatments are equally effective in relieving the impaired social functioning associated with depressive disorders. Expand
Psychosocial working conditions and work-related stressors among UK veterinary surgeons.
TLDR
Compared to the general population, the sample reported higher risk of work-related stress for demands and managerial support but lower risk for relationships and change. Expand
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
CONTEXT No large-scale posttraumatic stress disorder drug trials have been conducted to evaluate treatment effects beyond 12 weeks outside of those with selective serotonin reuptake inhibitors. … Expand
Benzodiazepines: Risks and benefits. A reconsideration
TLDR
The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs, and believed that the potential for dependence or other harmful effects must be considered whenever benzidiazepines are prescribed. Expand
...
1
2
3
4
5
...